Inventor · disambiguated record
Timothy Haystead
Also filed as: HAYSTEAD TIMOTHY · HAYSTEAD TIMOTHY A · HAYSTEAD TIMOTHY A J
17 granted patents·10 pending applications·62 citations·filing 1994–2024
90Inventor score
Top patents by PatentIndex Score
27 records- 0188US10207998B2Substituted benzimidazole and substituted benzothiazole inhibitors of transforming growth factor-β kinase and methods of use thereofUNIV DUKE·Filed 2017·Granted Feb 19, 2019·6 cites·21 claims
- 0287US9738643B2Substituted indazoles for targeting Hsp90UNIV DUKE·Filed 2013·Granted Aug 22, 2017·5 cites·10 claims
- 0380US10966981B2Fatty acid synthase inhibitorsUNIV DUKE·Filed 2017·Granted Apr 6, 2021·2 cites·26 claims
- 0476US2024279234A1Kinase inhibitors and related methods of useUNIV DUKE·Filed 2024·Application pending·0 cites
- 0574US10927115B2Substituted heterocycles for targeting Hsp90UNIV DUKE·Filed 2019·Granted Feb 23, 2021·0 cites·14 claims
- 0674US2024409504A1Compositions and methods for the treatment of cancerUNIV DUKE·Filed 2024·Application pending·0 cites
- 0771US5686310AMethod for determination of the amount of either phosphotyrosine or phosphoserine in a proteinUNIV VIRGINIA·Filed 1995·Granted Nov 11, 1997·26 cites·12 claims
- 0868US10442806B2Substituted heterocycles for targeting HSP90UNIV DUKE·Filed 2018·Granted Oct 15, 2019·0 cites·20 claims
- 0967US11999737B2Kinase inhibitors and related methods of useUNIV DUKE·Filed 2021·Granted Jun 4, 2024·0 cites·8 claims
- 1067US2022135572A1Compounds and methods for targeting hsp90UNIV DUKE·Filed 2022·Application pending·0 cites
- 1166US10112947B2Substituted 6-aminopurines for targeting HSP90UNIV DUKE·Filed 2017·Granted Oct 30, 2018·0 cites·14 claims
- 1264US12098117B2Compositions and methods for the treatment of cancerUNIV DUKE·Filed 2019·Granted Sep 24, 2024·0 cites·7 claims
- 1363US11767298B2Substituted benzimidazoles as inhibitors of transforming growth factor-β kinaseUNIV DUKE·Filed 2021·Granted Sep 26, 2023·0 cites·17 claims
- 1463US11679111B2Fatty acid synthase inhibitorsUNIV DUKE·Filed 2021·Granted Jun 20, 2023·0 cites·20 claims
- 1560US11261187B2Compounds and methods for targeting HSP90UNIV DUKE·Filed 2017·Granted Mar 1, 2022·0 cites·21 claims
- 1660US10934291B2Kinase inhibitors and related methods of useUNIV DUKE·Filed 2015·Granted Mar 2, 2021·0 cites·11 claims
- 1759US10927083B2Substituted benzimidazoles as inhibitors of transforming growth factor-β kinaseUNIV DUKE·Filed 2019·Granted Feb 23, 2021·0 cites·13 claims
- 1859US5536822Aγ-phosphate linked adenosine 5' triphosphate sepharoseUNIV VIRGINIA·Filed 1994·Granted Jul 16, 1996·19 cites·7 claims
- 1956US2024116893A1Compounds for Disease TreatmentUNIV DUKE·Filed 2022·Application pending·0 cites
- 2055US6716395B2Integrated protein affinity capture centrifugation deviceSERENEX INC·Filed 2001·Granted Apr 6, 2004·4 cites·18 claims
- 2155US2024299358A1Compositions and methods for diagnosis and treatment of autoimmune diseasesUNIV DUKE·Filed 2022·Application pending·0 cites
- 2251US2003017568A1Smooth muscle myosin phosphatase associated kinaseFiled 2002·Application pending·0 cites
- 2349US2007134752A1Smooth muscle myosin phosphatase associated kinaseUNIV DUKE·Filed 2005·Application pending·0 cites
- 2446US2009088578A1Nuclear magnetic resonance imaging of selective small molecule drugs as contrast agentsLASCOLA CHRISTOPHER D·Filed 2008·Application pending·0 cites
- 2542US2003143645A1Quinone reductase 2 and aldehyde dehydrogenase as therapeutic targetsFiled 2002·Application pending·0 cites
- 2636US10000469B2Heat shock protein 70 (hsp-70) receptor ligandsUNIV DUKE·Filed 2015·Granted Jun 19, 2018·0 cites·10 claims
- 2729US2016143884A1Use of tetrahydroindazolylbenzamide and tetrahydroindolylbenzamide derivatives for the treatment of human immunodeficiency virus (hiv) and acquired immune deficiency syndrome (aids)ESANEX INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →